Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Florida for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Florida only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Florida (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Nicholas Maruniak (NPI 1235190356)

Field	Value
Entity Type	Individual
Organization	Nicholas Maruniak
Address	12109 County Road 103
City	Oxford
State	FL
ZIP	34484
Taxonomy	Anatomic Pathology & Clinical Pathology Physician
NPI Enumerated	March 29, 2006

Payer Source	Total Paid
Medicare	$5.5M
Medicaid	$0

Key Findings

This provider’s payment footprint is effectively single‑payer: lifetime Medicare revenue is $5.5M while there is no Medicaid billing on file, so all documented public-payer activity is Medicare-driven and any Medicaid exposure is nil in the recorded data. That imbalance implies the operational and contracting focus shown here is concentrated on Medicare beneficiaries and Medicare fee schedules.

Revenue is strongly concentrated in a small set of laboratory/pathology services: the precomputed top 3 Medicare codes account for 51.6% of total Medicare revenue, driven by 87798 ($1.4M, 26.8% of Medicare revenue), 88120 ($878K, 16.7%), and 84153 ($424.2K, 8.1%). Those three codes alone make up over half of the provider’s Medicare receipts, which indicates a narrow set of services producing the bulk of income.

The code mix indicates a lab‑ and pathology‑centric operation with a heavy emphasis on molecular diagnostics and prostate-related testing. High-revenue codes include amplified nucleic acid probe procedures (87798) and anatomic/cytopathology procedures such as 88120 and G0416, while PSA testing (84153) and free PSA (84154) further point to substantial urology/prostate specimen volume.

The provider is a high-volume NAAT (nucleic acid amplification test) operator: multiple amplified probe codes appear in the top list with substantial claim counts and revenue, for example 87481 (7.6K claims, $259.3K), 87556 (3.2K claims, $132.6K), and 87651 (3.2K claims, $109.8K). This pattern — repeated listing of organism-specific NAAT codes — supports that molecular infectious-disease testing is a core service line rather than an occasional add-on.

On competitive standing the provider is a national outlier for several pathology services: 84153 ranks #28 of 8151 providers (100th percentile; labeled an "extreme outlier"), 88112 ranks #7 of 4868 (100th percentile; "extreme outlier"), and G0416 ranks #4 of 2465 (100th percentile; "extreme outlier"). At the same time 88120 ranks #6 of 232 (98th percentile; "notably above typical"), indicating dominant national positioning in multiple, high-value pathology niches.

The profile is heterogeneous across codes: some high-revenue items are flagged as "extreme outlier" or "notably above typical" while others are characterized as "typical, unremarkable" at similar percentiles (for example 87798 is #46 of 1319, 97th percentile; labeled "typical, unremarkable"), suggesting the provider is exceptional in specific specialty assays but more typical on broader lab services.

Operationally the practice combines very high throughput, low-unit‑price testing with lower-frequency, higher‑unit‑price procedures. For example, 84153 shows 23.6K claims at $18 avg paid/claim (total $424.2K), whereas 88120 is 1.9K claims at $454 avg paid/claim (total $878K); that mix is consistent with a lab that runs mass screening panels alongside specialized cytogenetic/cytopathology work.

The provider’s NPI was enumerated 2006-03-29 (~20 years ago), indicating long tenure in the Medicare program that aligns with sustained total Medicare revenue of $5.5M. Coupled with the absence of Medicaid billing on file, this longevity supports a stable, Medicare-focused practice footprint rather than recent or transient billing activity.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

61 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
87798	The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified…	41,330	$30	$1.4M
88120	The lab analyst performs a technical lab test on a urinary tract specimen using in situ hybridization and three to five molecular probes for manual morphometric analysis, looking at the number and…	1,930	$450	$878K
84153	The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and…	23,570	$20	$424.2K
88112	Selective cellular enhancement for cytopathology, such as the method of using a liquid–based slide preparation, uses a liquid–based medium to collect samples and preserve cells which can aid in…	7,440	$50	$372.1K
G0416	Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method	1,270	$280	$351.1K
87481	The lab analyst performs a test for Candida species using amplified nucleic acid probe technique.	7,630	$30	$259.3K
87086	Culture, bacterial; quantitative, colony count, urine.	22,550	$10	$180.4K
84403	The lab analyst performs a test to measure total testosterone, typically in patient serum.	5,330	$30	$133.3K
87556	The lab analyst performs a test for Mycobacterium tuberculosis using amplified nucleic acid probe technique. Mycobacteria tuberculosis are sometimes called acid fast bacteria because of the special…	3,240	$40	$132.6K
84154	The lab analyst performs a test to evaluate the level of free prostate specific antigen, called free PSA, in a patient specimen such as serum.	6,690	$20	$120.4K

Showing 1–10 of 61

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 61 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Florida Distribution

Nicholas Maruniak — 17 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Florida

Full comparison — all codes billed, vs. state median

61 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
87798	3	110	590	$30	$218.6K
88305	200	980	570	$40	$83.5K
88120	1	20	70	$350	$78K
87481	4	80	340	$30	$72.8K
87511	2	10	220	$30	$60.4K
87640	3	70	210	$30	$30.9K
87653	4	70	180	$30	$30.8K
87500	7	70	190	$30	$29.6K
87556	1	10	40	$40	$27.9K
87563	4	30	180	$30	$22.9K

Showing 1–10 of 61

Related Providers

Other providers that share a Tax Identification Number (TIN) with Nicholas Maruniak, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nicolas Zouain	FL	Radiation Oncology Physician	$2.4M	$0
Michael Chancellor	FL	Radiation Oncology Physician	$2.3M	$0
Paul Jo	FL	Specialist	$1.3M	$0
Hasan Murshed	FL	Radiation Oncology Physician	$1.2M	$0
Andrew Sher	FL	Urology Physician	$604.4K	$0
David Harris	FL	Urology Physician	$582.9K	$0
Denis Healey	FL	Urology Physician	$559K	$0
Mitchell Klavans	FL	Urology Physician	$546.3K	$0
Dinesh Rao	FL	Urology Physician	$492.4K	$0
Chad Hubsher	FL	Urology Physician	$474K	$0

Nearby Providers

Other providers in the same ZIP code as Nicholas Maruniak, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Advanced Surgery Center Of Oxford	FL	Ambulatory Surgical Clinic/Center	$3.1M	$0
Nalini Yelamanchi	FL	Internal Medicine Physician	$576.2K	$0
Saumilkumar Karavadia	FL	Urology Physician	$467K	$0
Richard Roach	FL	Urology Physician	$307.2K	$0
Carole Gordon	FL	Urology Physician	$249.1K	$0
Jennifer Montgomery	FL	Occupational Therapist	$148.3K	$0

Nicholas Maruniak — Billing Profile & Reimbursement Data

Sign up for Nicholas Maruniak — Billing Profile & Reimbursement Data policy alerts

Nicholas Maruniak — Billing Profile & Reimbursement Data

Sign up for Nicholas Maruniak — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References